Thieno[2,3-c]isoquinolines: A novel chemotype of antiproliferative agents inducing cellular apoptosis while targeting the G2/M phase and Tubulin

Bibliographic Information
Authors: Marae I.S.; Maklad R.M.; Samir S.; Bakhite E.A.; Sharmoukh W.
Journal: Drug Development Research
Publisher: John Wiley and Sons Inc
Publication Date: 31 March 2023
Volume / Issue: Volume 84 / Issue 4
Pages: 747–766
ISSN: 2724391
DOI: 10.1002/ddr.22054
Scopus: View on Scopus
PubMed: 36999479
Document Type: Article
Access: All Open Access; Bronze Open Access
Authors and Affiliations
Marae I.S., Department of Chemistry, Faculty of Science, Assiut University, Assiut, Egypt; Maklad R.M., Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt, Institute of Drug Discovery and Development, Kafrelsheikh University, Kafrelsheikh, Egypt; Samir S., Department of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute, Giza, Egypt; Bakhite E.A., Department of Chemistry, Faculty of Science, Assiut University, Assiut, Egypt; Sharmoukh W., Department of Inorganic Chemistry, National Research Centre, Giza, Egypt
Abstract
In the era of modern synthetic methodology and advanced bio-evaluation techniques and considering the notorious history of hepatocellular carcinoma (HCC), hopeful expectations regarding novel bioactive chemotypes have grown dramatically. Among the widely versatile motifs in drug discovery studies are isoquinoline and thieno[2,3-b]pyridine. Herein, the molecular merging of both motifs evoked thieno[2,3-c]isoquinoline as a novel antiproliferative chemotype being hardly studied against HCC. Accordingly, compound series 4, 5, 7 and 8 were synthesized and bioevaluated against the HepG2 cell line. The role of C7-Ac/C8-OH substituents, C8-C9 unsaturation, 1H-pyrrol-1-yl ring closure at C1-NH2 and C6-Ph p-halo-substitution were biologically studied and successfully furnished the lead 5b while showing safe profile against Vero cells. Further, flow cytometric and Annexin V-FITC/PI apoptotic bio-investigations of 5b unveiled remarkable cell cycle arrest at the G2/M phase besides a 60-fold increase in apoptosis. The use of a DFT conformational study followed by Molecular docking and molecular mechanics/generalized born surface area scoring evoked potential tubulin-targeting activity of 5b at colchicine-binding site, which was confirmed by experimental evidence (Tub Inhib IC50 = 71 µM vs. 14 µM for colchicine). Accordingly, preserving C7-acetyl and optimizing halogen position while preserving [6S,7R]-stereochemistry is crucial for optimum binding to colchicine binding site of tubulin. © 2023 Wiley Periodicals LLC.
Keywords
anticancer; apoptosis; flow cytometry; molecular modeling; thieno[2,3-c]isoquinoline; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Division; Cell Line, Tumor; Cell Proliferation; Chlorocebus aethiops; Colchicine; Drug Screening Assays, Antitumor; Humans; Isoquinolines; Liver Neoplasms; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Tubulin; Tubulin Modulators; Vero Cells; 1 amino 2 acetyl 5,8 dimethyl 6 phenyl 6,7 dihydrothieno[2,3 c]isoquinoline; 1 amino 2,7 diacetyl 5,8 dimethyl 8 hydroxy 6 phenyl 6,7,8,9 tetrahydrothieno[2,3 c]isoquinoline; 2 acetyl 5,8 dimethyl 6 phenyl 1 pyrrolyl 6,7 dihydrothieno[2,3 c]isoquinoline; 2,7 diacetyl 5,8 dimethyl 8 hydroxy 6 phenyl 1 (1h pyrrol 1 yl)6,7,8,9 tetrahydrothieno[2,3 c]isoquinoline; antineoplastic agent; fluorescein isothiocyanate; isoquinoline derivative; lipocortin 5; thieno[2,3 b]pyridine derivative; unclassified drug; tubulin modulator; antiproliferative activity; Article; binding site; cell cycle G2 phase; cell cycle M phase; controlled study; drug development; drug synthesis; evoked response; Hep-G2 cell line; human; human cell; liver cell carcinoma; molecular mechanics; stereochemistry; structure activity relation; surface area; Vero cell line; animal; chemical structure; chemistry; drug screening; liver tumor; metabolism; molecular docking; tumor cell line
Citation Information
Scopus Citations: 8
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
